Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A team of scientists from the US-based Cedars-Sinai Regenerative Medicine Institute (CSRMI) has been awarded a $1.9m grant from the California Institute for Regenerative Medicine (CIRM) to fund the development of a new technique to aid pharmaceutical discoveries for specific diseases.
Subscribe to our email newsletter
CSRMI Director Clive Svendsen and his team led by Dhruv Sareen were given this grant to invent a new pharmaceutical discovery process that employs pluripotent stem cells in order to find a pharmaceutical treatment for Spinal Muscular Atrophy.
Additionally, another team from the Cedars-Sinai Department of Surgery will share a $1.5m grant with a medical technology company to develop a new imaging system.
Svendsen said that these grants would allow continuous advancements in stem cell science and help reach the goal of a new era in treatment, especially for diseases that currently have no cure or standard treatment.